• Hausa Edition
  • Podcast
  • Conferences
  • LeVogue Magazine
  • Business News
  • Print Advert Rates
  • Online Advert Rates
  • Contact Us
Monday, June 30, 2025
Leadership Newspapers
Read in Hausa
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us
No Result
View All Result
Leadership Newspapers
No Result
View All Result

NAFDAC Raises Alarm Over Fake Perjeta Product In Nigeria

by OLAMIDE OJUOKAIYE and Sandra Simon
10 months ago
in News
Fake Perjeta Product.

Fake Perjeta Product.

Share on WhatsAppShare on FacebookShare on XTelegram

The National Agency for Food and Drug Administration Control (NAFDAC), has alerted healthcare providers and the public of a report of counterfeit Perjeta units being in circulation in Nigeria.

Advertisement

NAFDAC, in a release on its official website stated, “Marketing Authorization Holder (MAH) Roche received a complaint from a pharmacist reporting two units of suspected counterfeit Roche products, Perjeta 420 mg/14mL.

“The Kaiseraugst/Switzerland Quality Control organisation investigated the complaint sample pictures. As the batch number is not a genuine Roche batch number, a comparison against a batch corresponding retain sample was not possible. Since the sample may mimic the Roche common make-up EFA, a corresponding retain sample was used for comparison.”

However, significant differences were found about the packaging materials as the folding box (including the Tamper Evident label) does not correspond to Roche Perjeta’s genuine packaging material.

“Batch Trace: The lot tracing was impossible because the lot number imprinted is not a genuine Roche batch number for Perjeta,” the statement noted.

RELATED

June 12: Dangiwa Umar Reacts To National Honour By Tinubu, Reveals 38 Other ‘Unsung Heroes’

June 12: Dangiwa Umar Reacts To National Honour By Tinubu, Reveals 38 Other ‘Unsung Heroes’

7 minutes ago
Meet Top 20 Nigerian Techies Driving Innovations In 2025

Meet Top 20 Nigerian Techies Driving Innovations In 2025

11 minutes ago

It added that the chemical analysis was not possible as the physical complaint sample was not available for return.

According to NAFDAC, investigation on the provided pictures revealed clear evidence of counterfeit packaging material.

“Perjeta 420mg Injection is used to treat breast cancer when other medicines have failed to show significant improvement.

“It helps to stop cancer growth and further spread and relieves the symptoms of breast cancer such as breast lumps, bloody discharge from the nipple, or changes in the shape or texture of the breast,” NAFDAC stressed.

Healthcare professionals and consumers are therefore advised to report any suspicion of the sale of substandard and falsified medicines or medical devices to the nearest NAFDAC office.

Such complaints are also asked to me made through call or email to NAFDAC at 0800-162-3322, and [email protected].


We’ve got the edge. Get real-time reports, breaking scoops, and exclusive angles delivered straight to your phone. Don’t settle for stale news. Join LEADERSHIP NEWS on WhatsApp for 24/7 updates →

Join Our WhatsApp Channel

BREAKING NEWS: Nigerians can now earn US Dollars from the comfort of their homes with Ultra-Premium domains, acquire them for as low as $1700 and profit as much as $25,000. Click here to learn how you can earn US Dollars consistently.


Tags: National Agency for Food and Drug Administration and Control (NAFDAC)Perjeta
SendShareTweetShare
Previous Post

PICTORIAL: Jonathan, VP Shettima, PDP, APC Govs Storm Taraba For Gov Kefas’ Daughter’s Wedding

Next Post

Forex trading in Nigeria: Explore the opportunities, challenges, and strategies for success

OLAMIDE OJUOKAIYE and Sandra Simon

OLAMIDE OJUOKAIYE and Sandra Simon

You May Like

June 12: Dangiwa Umar Reacts To National Honour By Tinubu, Reveals 38 Other ‘Unsung Heroes’
News

June 12: Dangiwa Umar Reacts To National Honour By Tinubu, Reveals 38 Other ‘Unsung Heroes’

2025/06/30
Meet Top 20 Nigerian Techies Driving Innovations In 2025
Feature

Meet Top 20 Nigerian Techies Driving Innovations In 2025

2025/06/30
Abia Polls: Igbokwe Distances Self From Petition Against Reps’ Deputy Speaker Kalu
News

Kalu Seeks Debt Cancellation To Ease Africa’s Burden

2025/06/30
ICPC To Appeal Ruling On Yuguda’s Ex-Aide’s Case
News

Aviation Ministry Worker Convicted Over Employment Fraud

2025/06/29
Police Arrest Arrowhead Of Child Theft Syndicate, Rescue 12 Minors 
News

Police Arrest Arrowhead Of Child Theft Syndicate, Rescue 12 Minors 

2025/06/29
Despite Threats Of Reprisal, South East Calm
News

Soldiers Kill Terrorist Kingpin Mai Dada, Recover Weapons

2025/06/29
Leadership Conference advertisement

LATEST

June 12: Dangiwa Umar Reacts To National Honour By Tinubu, Reveals 38 Other ‘Unsung Heroes’

Meet Top 20 Nigerian Techies Driving Innovations In 2025

Kalu Seeks Debt Cancellation To Ease Africa’s Burden

Aviation Ministry Worker Convicted Over Employment Fraud

Police Arrest Arrowhead Of Child Theft Syndicate, Rescue 12 Minors 

Abakaliki FC In Minor Road Accident After Federation Cup Defeat

CWC: PSG Thrash Lionel Messi’s Inter Miami 4-0, Advance To Quarterfinals

Soldiers Kill Terrorist Kingpin Mai Dada, Recover Weapons

Abducted Benue Links Bus Passengers Regain Freedom After 1 Week In Captivity

Okunbo Foundation Expands Artistic Opportunity In Nigeria

© 2025 Leadership Media Group - All Rights Reserved.

No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Sport
  • Health
  • Entertainment
  • Opinion
    • Editorial
  • Columns
  • Football
  • Others
    • LeVogue Magazine
    • Conferences
    • National Economy
  • Contact Us

© 2025 Leadership Media Group - All Rights Reserved.